Skyhawk Signs its First Oncology Deal with Merck

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 7 (Table of Contents)

Published: 12 Jul-2019

DOI: 10.3833/pdr.v2019.i7.2439     ISSN: 1756-7874

Section: Research & Development



In a bid to secure growth drivers beyond Keytruda® (pembrolizumab), Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details